Results 141 to 150 of about 65,112 (159)

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021

Morbidity and Mortality Weekly Report, 2021
Wesley H Self, Ithan D Peltan, Akram Khan   +2 more
exaly  

Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells

Science, 2021
Jose Mateus, Jennifer M Dan, Zeli Zhang
exaly  

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

New England Journal of Medicine, 2021
Mark G Thompson, Allison L Naleway, Harmony L Tyner   +2 more
exaly  

mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern

Science, 2021
Rishi R Goel, Mark M Painter, Sokratis A Apostolidis   +2 more
exaly  

Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021

Morbidity and Mortality Weekly Report, 2021
Nicholas M Mohr, David A Talan, Karisa K Harland   +2 more
exaly  

Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario

Nature Microbiology, 2022
Sharifa Nasreen, Hannah Chung, Kevin A. Brown   +2 more
exaly  

Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine

ACS Nano, 2022
Yi Ju, Wen Shi Lee, Emily H Pilkington
exaly  

Lipid Nanoparticle–mRNA Formulations for Therapeutic Applications

Accounts of Chemical Research, 2021
Yi-Zhou Dong
exaly  

Utopias Tecnológicas, Estratégias e Realidades do Patrimônio da Arquitetura Moderna Brasileira: Uma Análise Gráfica da Habitação do Futuro proposta pelo Arquiteto Eduardo Longo. Pág. 98-125

CADERNOS DO PROARQ (UFRJ), 2022
Carlos Marcelo Campos Teixeira, Rafael Antonio Cunha Perrone, Renato Vizioli   +2 more
openaire   +1 more source

Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021

Morbidity and Mortality Weekly Report, 2021
exaly